These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

164 related articles for article (PubMed ID: 25917401)

  • 1. Cost-Effectiveness of Therapeutic Drug Monitoring in Diagnosing Primary Aldosteronism in Patients With Resistant Hypertension.
    Velasco A; Chung O; Raza F; Pandey A; Brinker S; Arbique D; Price A; Lotan Y; Das SR; Vongpatanasin W
    J Clin Hypertens (Greenwich); 2015 Sep; 17(9):713-9. PubMed ID: 25917401
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cost-Effectiveness of Screening for Primary Aldosteronism and Subtype Diagnosis in the Resistant Hypertensive Patients.
    Lubitz CC; Economopoulos KP; Sy S; Johanson C; Kunzel HE; Reincke M; Gazelle GS; Weinstein MC; Gaziano TA
    Circ Cardiovasc Qual Outcomes; 2015 Nov; 8(6):621-30. PubMed ID: 26555126
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Diagnosis of primary aldosteronism: value of different screening parameters and influence of antihypertensive medication.
    Seiler L; Rump LC; Schulte-Mönting J; Slawik M; Borm K; Pavenstädt H; Beuschlein F; Reincke M
    Eur J Endocrinol; 2004 Mar; 150(3):329-37. PubMed ID: 15012618
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The cutoff value of aldosterone-to-renin ratio for the diagnosis of primary aldosteronism in patients taking antihypertensive medicine.
    Niizuma S; Nakahama H; Kamide K; Fukuchi K; Iwanaga Y; Nakata H; Yoshihara F; Horio T; Nakamura S; Kawano Y
    Clin Exp Hypertens; 2008 Oct; 30(7):640-7. PubMed ID: 18855267
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comparison between screening for primary aldosteronism with and without drug adjustment.
    Hua Y; He Q
    Blood Press; 2024 May; 33(1):2350981. PubMed ID: 38824645
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Evaluation of aldosterone to direct renin ratio, low renin and related Phenotypes in Afro-Colombian patients with apparent treatment resistant hypertension.
    Durán CE; Bustamante M; Barbosa M; Useche EM; Triviño J; Sandoval L; Moncayo PA; Rivas AM; Zapata JS; Hernández Quintero JD; Meza S; Bolaños JS; Schweineberg J; Mesa L; Posada JG
    Sci Rep; 2024 Aug; 14(1):18091. PubMed ID: 39103362
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Screening for primary aldosteronism without discontinuing hypertensive medications: plasma aldosterone-renin ratio.
    Gallay BJ; Ahmad S; Xu L; Toivola B; Davidson RC
    Am J Kidney Dis; 2001 Apr; 37(4):699-705. PubMed ID: 11273868
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A case of primary aldosteronism with a negative aldosterone-to-renin ratio.
    Liu F; Wang L; Ding Y
    BMC Cardiovasc Disord; 2021 Jul; 21(1):350. PubMed ID: 34294029
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Potential cost-effectiveness of therapeutic drug monitoring in patients with resistant hypertension.
    Chung O; Vongpatanasin W; Bonaventura K; Lotan Y; Sohns C; Haverkamp W; Dorenkamp M
    J Hypertens; 2014 Dec; 32(12):2411-21; discussion 2421. PubMed ID: 25255395
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The aldosterone/renin ratio as a screening test for primary aldosteronism.
    Rayner BL; Opie LH; Davidson JS
    S Afr Med J; 2000 Apr; 90(4):394-400. PubMed ID: 10957926
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Screening Rates for Primary Aldosteronism in Resistant Hypertension: A Cohort Study.
    Jaffe G; Gray Z; Krishnan G; Stedman M; Zheng Y; Han J; Chertow GM; Leppert JT; Bhalla V
    Hypertension; 2020 Mar; 75(3):650-659. PubMed ID: 32008436
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Primary aldosteronism in a general population sample. The Czech post-MONICA study.
    Widimský J; Bruthans J; Wohlfahrt P; Krajčoviechová A; Šulc P; Linhart A; Filipovský J; Lánská V; Cífkova R
    Blood Press; 2020 Jun; 29(3):191-198. PubMed ID: 32036692
    [No Abstract]   [Full Text] [Related]  

  • 13. High prevalence of primary aldosteronism using postcaptopril plasma aldosterone to renin ratio as a screening test among Italian hypertensives.
    Rossi E; Regolisti G; Negro A; Sani C; Davoli S; Perazzoli F
    Am J Hypertens; 2002 Oct; 15(10 Pt 1):896-902. PubMed ID: 12372677
    [TBL] [Abstract][Full Text] [Related]  

  • 14. RAS-challenge as a first-look test for detection of primary aldosteronism in patients with treatment-resistant hypertension.
    Beger C; Karg T; Hinrichs JB; Ringe B; Haller H; Meyer BC; Limbourg FP
    Blood Press; 2023 Dec; 32(1):2179340. PubMed ID: 36803263
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Screening for primary aldosteronism in essential hypertension: diagnostic accuracy of the ratio of plasma aldosterone concentration to plasma renin activity.
    Schwartz GL; Turner ST
    Clin Chem; 2005 Feb; 51(2):386-94. PubMed ID: 15681560
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Adherence to Antihypertensive Medication in Treatment-Resistant Hypertension Undergoing Renal Denervation.
    Schmieder RE; Ott C; Schmid A; Friedrich S; Kistner I; Ditting T; Veelken R; Uder M; Toennes SW
    J Am Heart Assoc; 2016 Feb; 5(2):. PubMed ID: 26873693
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Primary aldosteronism: emerging trends.
    Galati SJ; Hopkins SM; Cheesman KC; Zhuk RA; Levine AC
    Trends Endocrinol Metab; 2013 Sep; 24(9):421-30. PubMed ID: 23796656
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Ratio of serum aldosterone to plasma renin concentration in essential hypertension and primary aldosteronism.
    Trenkel S; Seifarth C; Schobel H; Hahn EG; Hensen J
    Exp Clin Endocrinol Diabetes; 2002 Apr; 110(2):80-5. PubMed ID: 11928071
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Screening for primary aldosteronism in a primary care unit.
    Volpe C; Wahrenberg H; Hamberger B; Thorén M
    J Renin Angiotensin Aldosterone Syst; 2013 Sep; 14(3):212-9. PubMed ID: 23118039
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Influence of antihypertensive medication on aldosterone and renin concentration in the differential diagnosis of essential hypertension and primary aldosteronism.
    Seifarth C; Trenkel S; Schobel H; Hahn EG; Hensen J
    Clin Endocrinol (Oxf); 2002 Oct; 57(4):457-65. PubMed ID: 12354127
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.